In this large multi-center trial of patients with acute symptomatic PE (PE severity index class I or II), they were randomized to in or outpatient treatment with LMWH. There were no significant differences between the groups in 90 day recurrent VTE, death, or major bleeding. LOS was 0.5 days vs 3.9 days. Outpatient therapy is feasible, safe, and lower cost in low risk patients with PE (abstract)
Archives
Categories
- Cardiology (248)
- GI (122)
- Hematology and Oncology (159)
- ID (247)
- Influenza (39)
- Neurology (86)
- Other (241)
- Peri-Operative Medicine (91)
- Pulmonary and Critical Care (177)
- Renal (31)
Quick Links
Meta